Anzen Industries
United States · Biotech · Industrial tech
Anzen Industries, now operating as Tera, develops modular cell-free enzyme reactors for manufacturing high-value chemicals.
Making complex molecules outside living cells
Anzen Industries, now operating as Tera, develops manufacturing technology for chemical producers seeking more controllable supplies of complex molecules. Its cell-free approach isolates enzymes and uses them to carry out chemical reactions in small, modular systems.
The platform combines reusable enzyme reactors, enzyme immobilization and computational design. By controlling the reaction outside a living cell, the company aims to make production more flexible and reduce dependence on large fermentation infrastructure. Its founders describe applications across the chemical industry, including cosmetics and pharmaceuticals. The company established its next phase of operations in California.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Pre-seed | $2.2M | Creator Fund — LeadLocalGlobe — LeadCory Levy — ParticipantKonstantin von Unger — Participant |